Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
Patrick Wainwright, Eleonora Scorletti, Christopher D. Byrne
Current Diabetes Reports (2017) Vol. 17, Iss. 4
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Update in global trends and aetiology of hepatocellular carcinoma
Prashanth Rawla, Tagore Sunkara, Pradhyumna Muralidharan, et al.
Współczesna Onkologia (2018) Vol. 22, Iss. 3, pp. 141-150
Open Access | Times Cited: 300
Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis
Bei Li, Chuan Zhang, Yutao Zhan
Canadian Journal of Gastroenterology and Hepatology (2018) Vol. 2018, pp. 1-8
Open Access | Times Cited: 143
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani, Giovanni Targher
Annals of Translational Medicine (2017) Vol. 5, Iss. 13, pp. 270-270
Open Access | Times Cited: 141
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101215-101215
Open Access | Times Cited: 132
Diabetes and cancer: Epidemiological and biological links
Mina Wang, Yingying Yang, Zehuan Liao
World Journal of Diabetes (2020) Vol. 11, Iss. 6, pp. 227-238
Open Access | Times Cited: 122
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, et al.
Cancer Letters (2024) Vol. 597, pp. 217061-217061
Closed Access | Times Cited: 10
Associations between Diabetes Mellitus and Selected Cancers
Monika Pliszka, Leszek Szablewski
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7476-7476
Open Access | Times Cited: 8
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Fredrik Åberg, Martti Färkkilâ
Seminars in Liver Disease (2020) Vol. 40, Iss. 02, pp. 154-162
Open Access | Times Cited: 61
The biological and pharmacological connections between diabetes and various types of cancer
Xuechang Wang, Suming Ding
Pathology - Research and Practice (2021) Vol. 227, pp. 153641-153641
Closed Access | Times Cited: 52
Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis
Sabkat Mahmud, Alvira Ajadee, Arnob Sarker, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319028-e0319028
Open Access
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
Agostino Di Ciaula, Leonilde Bonfrate, Marcin Krawczyk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2636-2636
Open Access | Times Cited: 16
High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway
Xin Li, Ting Cheng, Yuan He, et al.
Life Sciences (2019) Vol. 232, pp. 116602-116602
Closed Access | Times Cited: 26
Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis
Chien–Yu Lin, Pratik Adhikary, Kun Cheng
Advanced Drug Delivery Reviews (2021) Vol. 174, pp. 127-139
Open Access | Times Cited: 23
Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
Tingting Shi, Hideki Kobara, Kyoko Oura, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 45-55
Open Access | Times Cited: 22
The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China
Yifei Tan, Xiaoyun Zhang, Wei Zhang, et al.
Cancer Epidemiology Biomarkers & Prevention (2019) Vol. 28, Iss. 12, pp. 2038-2046
Closed Access | Times Cited: 25
Cancer of the Liver and its Relationship with Diabetes mellitus
Sunday Amos Onikanni, Bashir Lawal, Oluwafemi Shittu Bakare, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 14
Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugs
Evgenia Koureta
Annals of Gastroenterology (2023)
Open Access | Times Cited: 4
Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients
Jian Wang, Yifan Pan, Ye Xiong, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 11, pp. 1457-1458
Closed Access | Times Cited: 1
Identification of key markers for the stages of nonalcoholic fatty liver disease: An integrated bioinformatics analysis and experimental validation
Itayetzi Reyes-Avendaño, Ana B. Villaseñor-Altamirano, Edilburga Reyes-Jiménez, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 11, pp. 1887-1896
Closed Access | Times Cited: 1
A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
Lin‐Lin Cao, Yi Han, Lin Pei, et al.
Metabolites (2022) Vol. 12, Iss. 7, pp. 610-610
Open Access | Times Cited: 7
Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
Zhihong Yue, Lin Pei, Guangyan Meng, et al.
Metabolites (2023) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 3
Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinoma
Xiangkun Wang, Xiwen Liao, Xin Zhou, et al.
American Journal of Cancer Research (2020) Vol. 10, Iss. 12, pp. 4178-4197
Closed Access | Times Cited: 8
Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset non-alcoholic fatty liver disease and hepatocellular carcinoma in type 2 diabetes mellitus: A population-based study
Oscar Hou In Chou, Jing Ning, Raymond Chan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis
Anna Mrzljak, Maja Cigrovski Berković, Francesco Giovanardi, et al.
Croatian Medical Journal (2022) Vol. 63, Iss. 2, pp. 176-185
Open Access | Times Cited: 4
Diabetes mellitus affects long-term survival in hepatitis B virus-related hepatocellular carcinoma patients
Haili Zhang, Hongyu Li, Lan Xiang, et al.
Medicine (2021) Vol. 100, Iss. 4, pp. e24354-e24354
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top